Rheumatic Myocarditis Treatment Market Share

North American Market Forecast

The North America industry is likely to account for largest revenue share of 35% by 2037. The growth of the market can be attributed majorly to the increasing frequency of rheumatic fever and subsequently rheumatic myocarditis amongst several people, backed by rising awareness about the disease among people and high healthcare expenditure for treatment procedures. For instance, the Centers for Medicare and Medicaid Services stated that the National Health Expenditure (NHE) of Americans grew almost 2.7% to reach USD 4.3 trillion which is also equivalent to USD 12,914 per person in 2021. It has also been calculated that national healthcare expenditure accounted for approximately 18.3% of the nation’s total Gross Domestic Product (GDP). Further, the presence of a strong healthcare network in the region, along with the availability of supportive advanced therapy medicinal products  to develop efficient treatment options, are also anticipated to contribute to market growth in the region. In addition, the high expenditure for expanding the healthcare industry and rising initiatives by the government to increase the awareness level about the disease in the region are also anticipated to spur market growth during the forecast period.

APAC Market Statistics

The Asia Pacific rheumatic myocarditis treatment market, amongst the market in all the other regions, is projected to hold the second largest share of about 24% during the forecast period. The major factor for market growth is the rising pool of patients diagnosed with chronic diseases which leads to rheumatic fever and rheumatic myocarditis. Also, the presence of biobanking and e-prescribing in the region is estimated to bring favorable options for the adoption of rheumatic myocarditis treatment among the people living in the region. Furthermore, the presence of major key players in the region and their increased active participation in developing novel techniques for rheumatic myocarditis treatment is also estimated to bring lucrative growth opportunities for market growth during the forecast period.

Europe Market Forecast

Further, the market in Europe, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2037. The rising initiatives by the major key players and the European government to increase the awareness level of the disease and its treatment coupled with the rising shift of people towards health and fitness are considered to be major factors for market expansion in the region in the upcoming years.